跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-GLICLAZIDE TABLET 80MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-GLICLAZIDE TABLET 80MG
Approved
THERAPEUTIC
APO-GLICLAZIDE TABLET 80MG
APOTEX INC.(150 SIGNET)
🇸🇬 Health Sciences Authority
Approval Date
May 15, 2008
Approval ID
8aeb17648a97d3a7
Company
APOTEX INC.(150 SIGNET)
Type
Therapeutic
Approval Details
Approval Id
8aeb17648a97d3a7
Drug Name
APO-GLICLAZIDE TABLET 80MG
Product Name
APO-GLICLAZIDE TABLET 80MG
Approval Number
SIN13468P
Approval Date
2008-05-15
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
A10BB09
Atc Item Name
gliclazide
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
GLICLAZIDE
80 mg
GLICLAZIDE
80 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 15, 2008
Approval ID
8aeb17648a97d3a7
Type
Therapeutic
Back to HSA Approvals